Catherine Stevens
Family · Fort Myers, FLNPI 1669923041
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $43.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$598
- Lilly USA, LLC$496
- Merck$342
- Collegium Pharmaceutical, Inc.$329
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$250
- Eisai Inc.$244
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $598 |
| Lilly USA, LLC | 5 | $496 |
| Merck | 11 | $342 |
| Collegium Pharmaceutical, Inc. | 30 | $329 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $250 |
| Eisai Inc. | 2 | $244 |
| Xeris Pharmaceuticals, Inc. | 2 | $230 |
| Axsome Therapeutics, Inc. | 2 | $219 |
| Amgen | 3 | $212 |
| Pfizer | 5 | $176 |
| Neurocrine Biosciences, Inc. | 1 | $137 |
| AstraZeneca | 1 | $122 |
| Bayer | 1 | $119 |
| Alnylam Pharmaceuticals Inc. | 1 | $119 |
| Gilead | 1 | $119 |
| Sanofi-aventis U.S. LLC | 1 | $114 |
| Biomerieux Inc | 1 | $103 |
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
| Dexcom, Inc. | 1 | $100 |
| Teleflex LLC | 1 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $80 |
| Biohaven Pharmaceuticals, Inc. | 1 | $76 |
| Neurelis, Inc. | 1 | $63 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Coastal Medical Technologies LLC | 2 | $36 |
| Si-bone, Inc. | 2 | $36 |
| Averitas Pharma Inc. | 1 | $25 |
| Novartis | 1 | $20 |
| USWM, LLC | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,701 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 15 | $521 |
| Tizanidine Hcl | 27 | $290 |
| Duloxetine Hcl | 11 | $150 |
| Ibuprofen | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Myers
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.